Company profile
Microbot Medical Inc.
NASDAQ: MBOT · Healthcare · Medical - Instruments & Supplies
#1039 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
54DFH 55DQ 40GM 72SS 69
v0.1 · 65/100 weight · provisional
↑ balance-sheet leverage, listing tenure · ↓ operating margin, net margin
Methodology →Revenue TTM
$346.0k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$13.1M
Employees
43
as of 2026-08-18
Market cap
$67.0M
as of 2026-08-18
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$116.9k$116.9k2015
Net income-$13.1M-$13.1M2025
Operating income-$14.7M-$14.7M2025
Total assets$81.5M$81.5M2025
Liabilities$4.0M$4.0M2025
Equity$77.6M$77.6M2025
Revenue trend
FY2014 – FY2015 · USD
FY14
FY14
FY15
FY14
FY15
FY15
FY15
FY15
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Microbot Medical Inc.’s revenue?
Microbot Medical Inc. booked $116.9k in FY2015 revenue, growing 216% year over year — faster than 90% of Healthcare companies we track, at a -11243.3% net margin.
Peers · Healthcare
AI/ML Innovations Inc.——Viracta Therapeutics, Inc.——Soligenix, Inc.42DBullfrog AI Holdings, Inc. Common Stock30DCreative Edge Nutrition, Inc.——Forza Innovations Inc.——Neighbors
Plymouth →Key facts
CEOHarel Gadot
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersHingham, MA
ExchangeNASDAQ: MBOT
Employees43
IPO date1992-03-25
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.